Establishment of Patient-Derived Organoids for Guiding Personalized Therapies in Breast Cancer Patients

Scientists established 75 patient-derived breast cancer organoid models. The results of H&E staining, immunohistochemical, and whole-exome sequencing revealed that patient-derived organoids inherited the histologic and genetic characteristics of their parental tumor tissues.